chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via interactive digital media and described the occurrence of injection site injury in a patient who received DTPa vaccine. On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced injection site injury. On an unknown date, the outcome of the injection site injury was unknown. The reporter considered the injection site injury to be possibly related to DTPa vaccine. Additional details were reported as follows: This case was reported by a consumer via Interactive Digital Media. The age at vaccination was not reported. The reporter stated that, the vaccine was mutated and didn't give lifetime protection. The reporter had two family members that were injured from the DTaP vaccine. This case has been linked with US2017GSK139613 as reported by the same reporter.
Pt called our office on 9/6/04 with complaints of pain and burning sensation at injection site (left deltoid) and pain and burning in both legs, second call 9/9/04: pt continues to have pain, burning and tingling sensation in legs, arms, and hands. 3rd call: 9/15/04: continues to have above symptoms. Was seen by neurologist. Pt informed us that her neurologist diagnosed her with a reaction from the vaccine and has requested we initiate this reports to VAERS.
generalized aching; pain in arm; fever; This spontaneous case was reported by an other and describes the occurrence of PAIN (generalized aching), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced PAIN (generalized aching), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever). At the time of the report, PAIN (generalized aching), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.4 (High) fever of 100.4 for about 24 hours and 99 (High) few days later had a fever of 99.         Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact
1 of 4 pts vaxed from the same Tetramune lot exp a fever 102-103, irritability (crying) w/in 1 hr p/vax & inject site react described as swelling & redness; This pt also recvd Orimune concomitantly; pt recovered;
Develops shingles on right side of face (under eye/nose)--itchy, painful, blisters. Tx:  Famvir 500mg QID x 10 days.
Rash scattered in 4 extremities more in face(cheeks) Plaques of pinpoint eruption in legs
Experienced very mild chest pain starting on 11/28/2021. Also experienced premature atrial contractions on 11/30/2021 through 12/02/2021. Rhythm recorded using an ECG device.
An unknown angry caller stated that he had a racing heart after taking moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (An unknown angry caller stated that he had a racing heart after taking moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (An unknown angry caller stated that he had a racing heart after taking moderna vaccine). At the time of the report, PALPITATIONS (An unknown angry caller stated that he had a racing heart after taking moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant Concomitant Medications were reported. No Treatment Information Provided.
migraines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Jun2021 10:15 (Lot number: EW0173) at the age of 29 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (product: COVID 19 , brand: Pfizer, lot number: Ew0172, lot unknown: False, administration date: 21May2021, administration time: 10:15 AM, dose number: 1, vaccine location: Left arm), administration date: 21May2021, when the patient was 29 years old, for covid 19 immunization. The following information was reported: MIGRAINE (non-serious) with onset 01Jul2021, outcome "not recovered", described as "migraines". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of migraine.  Additional information: I have been having migraines at least once a week since I have gotten the vaccine. I asked a colleague who also had gotten Pfizer and they have the same effects. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient tested covid post vaccination. Covid test post vaccination: test type post vaccination: Nasal Swab. Known allergies: No.    No follow-up attempts are possible. No further information is expected.
INCORRECT PRODUCT STORAGE; ADMINISTRATION OF VACCINE THAT  WAS STORED OUTSIDE OF THE RECOMMENDED STORAGE CONDITIONS; This spontaneous report received from a health care professional concerned a 31 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809 expiry: 4-AUG-2022) dose was not reported, administered on 11-JAN-2022 for prophylactic vaccination. Age at time of vaccination 31 years old. No concomitant medications were reported.  On 11-JAN-2022, the patient experienced administration of vaccine that was stored outside of the recommended storage conditions. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine that was stored outside of the recommended storage conditions and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20220558340, 20220558343, 20220558345, 20220558349, 20220558378, 20220558383, 20220558390, 20220558439, 20220558455, 20220558511, 20220558598, 20220558638 and 20220558852.
after my first vaccination I had a super heavy period that lasted 10 days; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EW0161, Expiration date was not reported), via an unspecified route of administration (administered on the light arm, as reported) on 23Apr2021 15:30 (at the age of 34-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included sulfer and penicillin allergy from an unknown date. Concomitant medication included ascorbic acid, biotin, boron citrate, calcium pantothenate, calcium phosphate, choline bitartrate, chromium picolinate, colecalciferol, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, inositol nicotinate, potassium iodide, pyridoxine hydrochloride, retinol palmitate (VITAFUSION WOMEN'S) taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. On an unspecified date, the patient experienced after my first vaccination I had a super heavy period that lasted 10 days. No treatment was received for the event. Since the vaccination the patient has not been tested for COVID-19. The outcome of the event was unknown.
This spontaneous report as received from a physician assistant refers to a 40 year old male patient with none pertinent medical history and drug allergies. On an unknown date the patient was vaccinated with one dose of M-M-R II, (lot#, expiration date, dose and route not reported). On 13-AUG-2014, blood titer was performed and the titer was drawn, which was negative for mumps antibodies, equivocal for measles antibodies, and positive for rubella antibodies. No treatment was given for the events. The patient's present status was unspecified. The outcome of the events was unknown. Additional information has been requested.
Pt called complaining of itchy nose and increased heart rate at 16:30 had taken benadryl and S/S had resolved. She felt it was r/t IZ but declined to be seen.
My arm was just a little sore the first three days after vaccination. On the evening of the 9th day my are seemed tender to the touch and when I looked, it was red and started to swell at the vaccination site and a few spots below it. I sent my doctor a picture and he prescribed Cephalexin 500mg on January 25 in case it was an infection.  My arm is no longer tender but it's still red and a bit swollen. It hasn't gotten any worse since yesterday.
pt recv vax 21AUG96 & 3SEP96 w/rash all over measles like eruption all over 2 days prior to ran fever & fussiness
felt tired; achy; She feels run down still; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st August 2020, the patient received the 1st dose of Shingrix. On 31st August 2020, less than a day after receiving Shingrix, the patient experienced tiredness, pain and feeling bad. On an unknown date, the outcome of the tiredness, pain and feeling bad were recovering/resolving.   It was unknown if the reporter considered the tiredness, pain and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and felt tired and achy. The reporter feels run down still but it was lessening as time goes on. The reporter did not consent to follow up.
Mother reports took child to ER 1/15/05 PM for cellulitis lt upper arm, red swollen warm some fever also had a scratch on very upper arm, mom states unsure cause of cellulitis but find out which vaccines on left arm in case anything else happens. Was given antibiotics and applied warm clothes, much better now.
Irregular vaginal bleeding and postcoital bleeding since first dose and not improvement since. Bleeding is moderate and occurs after and during sexual inter course as well as sporadically for a few days at a time every 1-2 weeks
headache, body aches, pain at injection site, tiredness, stomach upset, low fever  took ibuprofen and Tylenol for aches and headache
The morning after the booster shot, I woke up with ear fullness and pressure in both ears that has persisted for over 3 weeks. There is also occasional burning/ringing as well.
Referred to health dept. by Dr. for yellow fever and typhoid vaccines.  Stated after receiving typhoid shot on 7/20/09 she broke out in hives.  She book benadryl and hives got better.  Came to health dept late am with complaint of hives.  On exam, patient did have hives on extremities and back.  No complaint of shortness of breath or difficulty breathing.  She has appt with PMD at 3 pm today.  Instructed to go to ER if symptoms increase.  Talked to patient after PMD visit.  Started on prednisone.
Patient called me at the pharmacy on 10/10/15 complaining that her arm was hurting all night and she could not sleep.  She got the flu vaccine from her PCP on 10/8 then Prevnar from our pharmacy on 10/9, both in the left arm as requested. She said the injection site was red and swollen. I advised her to put a cold compress on the painful area and to take ibuprofen that was prescribed by her PCP.  I called the on-call physician who said that the patient is experiencing a normal reaction and should apply a cold compress and take ibuprofen or acetaminophen.  I called the patient back 1 hour later to let her know and check up on her, she said that she was feeling much better than before. The patient came to the pharmacy today and spoke with pharmacist saying the pain has not gone away, and she has a red band around her arm that is spreading.  Pharmacist advised her to draw a line around the red-band on her arm to note the change over time and to go to the hospital right away.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown demographics. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about October 2016, the patient was inoculated with ZOSTAVAX by a healthcare provider as recommended for permanent prevention and protection against shingles and zoster-related conditions (dose, route, and lot # not provided). On an unknown date, the patient was diagnosed with shingles and/or zoster related injuries after and despite being inoculated with ZOSTAVAX vaccine and suffered serious mental and physical pain and suffering and required extensive medical care and treatment. On or about December 2016, the patient was treated by a healthcare provider for shingles. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other medical related expenses which includes but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications and supplies. The outcome of the events was unknown. Causality assessment was related.
His entire upper arm is hot and red and slightly swollen. Haven't contacted Dr yet since I have read it's a typical reaction but after reading blogs about filing one of these I figured I should since he was diagnosed on the autism spectrum..
C/O dizzy, blurred vision, SOB, Right arm severe pain and tremors with Rt sided neck pain/spasms.  Brought to Medical Tent by W/C.  Verbalized had a Rt sides stroke 10 years ago, hx of pain/spasms in Rt arm if irritated.  Had not eaten or drank fluids.  Given OJ and Gatorade.  Ice applied to neck & upper arm.  No redness, rash/hives at injection site.  Vitals stable.  Home with wife after observation of 30 minutes.  Advised to f/u with primary care physician if further adverse reactions.  Advised not to have vaccinations in Rt arm.
Patient's left arm became very swollen, painful, red, and hot following her Pneumovax vaccination. She stated that it continued to spread and was all the way down to her elbox at time of reporting.
Pt reported to me on 12/11/13 that she had reaction w/pain & swelling of right arm, extending from deltoid area (site of Td vaccination down to forearm) following previous immunization. She was subsequently hospitalized, for a period of 10days for "inflammation & infection". Pt's hx is consistent w/ severe Arthus-like reaction to Td.
Pt here for unscheduled nurse visit for c/o redness of RUE. Pt received  Pneumovax on 3/14/16 and now with diffuse redness/warmth of upper portion of RUE. Slight edema noted. Afebrile at 98.7. No pain unless touched per pt report. Provider examined patient briefly: Patient reports that redness immediately erupted around Pneumovax injection  site. EXAM: VSS. SKIN: 8 sm wheal R UE at site of Pneumovax injection. A/P: atopic dermatitis; trial of prednisone and Benadryl; patient was advised to call immediately if no improvement or to go to ER if there is worsening.
got flu vaccine with thimersol had 3 inch hive develop below injection site heat redness swelling of deltoid worse evening of 11/05/2007
0200 AM patient awoke to sudden onset left lower quadrant & periumbilical abdominal pain, nausea and vomiting, unable to keep any semisoft food or water down for almost 12 hours. Family took to urgent care. Urgent care discovered hypoxia and called 911. COVID-19 vaccine #1 August 10, 2021, and COVID-19 vaccine #2 September 7, 2021.
Information has been received from a medical assistant concerning a 15 year old male patient. The patient's concurrent condition, medical history and concomitant therapy information was not provided. On 26-AUG-2013, the patient was vaccinated with the first dose of GARDASIL (lot # J006236, expiration date 25-FEB-2016) (strength and dose were not reported) intravenously for prophylaxis and on 04-SEP-2014, the patient was vaccinated with the second dose of GARDASIL (lot # J009243, expiration date 23-APR-2016) (strength and dose were not reported) intravenously for prophylaxis (Inappropriate schedule of vaccine administered). No adverse effects were reported. Additional information has been requested.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 42-year-old female subject who was vaccinated with Flulaval (GlaxoSmithKline) for prophylaxis.  On 17 October 2007, the subject received a 0.5 ml dose of Flulaval "below the deltoid" in an unspecified arm.  On 18 October 2007, approximately one day after vaccination with Flulaval, the subject experienced injection site redness.  At the time of reporting the outcome of the event was unspecified.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 06-MAR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 32 degrees Fahrenheit (0 degrees Celsius) (lowest recorded temperature) for 304 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Bronchitis; Arm pain; A spontaneous report  was received from a consumer for a 57 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, chills, cough and arm pain and diagnosed with bronchitis.  The patient's medical history was not provided. Concomitant product use included alprazolam.  On 29 Jan 2021, the patient received the first of two planned doses of mRNA-1273 (Lot number: 029C20A) and on 26 Feb 2021, she received the second of two planned doses of mRNA-1273 (Lot number: 001A21A) intramuscularly in left non dominant arm for prophylaxis of COVID-19 infection. On 26 Feb 2021 in evening around 8 PM, after receiving the vaccine, patient got fever, chills, cough and arm pain. On 01-Mar-2021, her doctor did Covid test and it resulted negative. She was then diagnosed with bronchitis and was prescribed Zithromax as treatment. She wanted to know if she could take Tylenol.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The outcome of the events was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Presented to emergency department on 4/7/21 with complaints of lightheadedness and feeling like he was going to pass out. He was found to be COVID-19 positive at that time and was deemed stable to return to home.  Patient presented to emergency again on 4/24/21 with worsening symptoms of shortness of breath and coughing for past week. He was admitted for further management. He is still admitted at time of writing.
I had minor breathing problems. I had a hard time taking deep breaths, my throat started to close. My airway felt restricted
Mild shortness of breath, mild chest pain, soon after waking up day after injection, off and on
Child seizured within 24 hours of receiving DPT. Child had no prior history of seizures. Dilatin, Phenobarb ordered.
Severe pain of the left arm; left chest pain; Severe pain of the left arm; left chest pain; This is a spontaneous report received from a non-contactable consumer or other non hcp.A 56 years old adult male patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 04Apr2021 10:00,at the age of 56 years old, as Dose 2,single for covid-19 immunization.The patient medical history was not reported.There were no concomitant medications.The patient experienced severe pain of the left arm; left chest pain on 04Apr2021 02:00.The outcome of the events was recovering.The patient previously received his 1st dose of Pfizer covid vaccine on 14Mar2021,01:45 PM.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 12 hours of vaccination injection site red, swollen itching. In about 2 hours rash, red raised areas to entire extremity, abdomen and back.
Rash-red, raised, itchy, warm to the touch, developed around the injection site 1 week post-initial injection.
Headache, SkinRash, rash and bruising localized to site, chills and migraine Narrative:  Other Relevant History:
Case number PHEH2015US000676, is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 69 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 14554P) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours.  The pharmacist does not believe that the vaccine was frozen instead thinks it was thermometer malfunction. No adverse event was reported following the maladministration (incorrect storage of drug). No further information was provided.
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Additional Details: Patient taken to the emergency room, they run EKG, chest x-ray and blood work. According to mom, they found no sign and symptom of myocarditis. Patient is still febrile (101)at day 6 of vaccination. At the EMS the patient was diagnosed for prolonged immune response.